Trials / Completed
CompletedNCT05874531
End-expiratory Occlusion Test and Prediction of Preload Dependence
End-expiratory Occlusion Test and Prediction of Preload Dependence: Echocardiographic and Hemodynamic Study in the ICU.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Mongi Slim Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Three sets of measurements of hemodynamic parameters and sub-aortic VTI were performed: before and at the end of 15 seconds end-expiratory occlusion and after 250 mL saline administration over 10 minutes. Patients were considered responders to fluid loading after an increase in sub-aortic VTI of more than 10% following a volume expansion. SPSS was used for statistic study. A p \< 0.05 was considered significant. The investigators performed univariate and then multivariate analysis.
Detailed description
The patients included were in the supine position in a prone position at 30°. They had continuous monitoring by: electrocardioscopy; pulse oximetry and invasive blood pressure. Diuresis was monitored hourly. A venous access to the superior vena cava territory (central venous catheter) was set up. The patients were sedated with a Ramsay score \> 4 and ventilated in controlled assisted mode. The sub-aortic TVI (in cm) was measured in an apical 5-chamber section by pulsed Doppler using a 1-5 MHz ultrasound probe (M-Turbo sonosite). Three sets of measurements of hemodynamic parameters and sub-aortic VTI were performed: before and at the end of 15 seconds end-expiratory occlusion and after 250 mL saline administration over 10 minutes. At each point, the investigators noted the hemodynamic, ultrasound and biological parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | End-expiratory occlusion test | 15 seconds end-expiratory occlusion |
Timeline
- Start date
- 2023-05-15
- Primary completion
- 2023-08-15
- Completion
- 2023-09-15
- First posted
- 2023-05-25
- Last updated
- 2023-09-25
Locations
1 site across 1 country: Tunisia
Source: ClinicalTrials.gov record NCT05874531. Inclusion in this directory is not an endorsement.